Paloma Partners Management CO Blueprint Medicines Corp Transaction History

Paloma Partners Management CO

  • $3.08 Billion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2020

May 15, 2020
SELL
$48.11 - $82.22 $226,165 - $386,516
-4,701 Closed
0 $0
Q4 2019

Feb 14, 2020
BUY
$66.73 - $82.59 $313,697 - $388,255
4,701 New
4,701 $377,000
Q2 2019

Aug 14, 2019
SELL
$73.54 - $97.8 $511,764 - $680,590
-6,959 Closed
0 $0
Q1 2019

May 15, 2019
BUY
$48.7 - $86.6 $338,903 - $602,649
6,959 New
6,959 $557,000

Others Institutions Holding BPMC

# of Institutions
350
Shares Held
60.3M
Call Options Held
2.25M
Put Options Held
1.18M
View Full List

About Blueprint Medicines Corp

BPMC Quotes by TradingView
  • Ticker BPMC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,719,600
  • Market Cap $5.3B
  • Description
  • Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...
More about BPMC
Track This Portfolio

Track Paloma Partners Management CO Portfolio

Follow Paloma Partners Management CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Paloma Partners Management CO, based on Form 13F filings with the SEC.

News

Stay updated on Paloma Partners Management CO with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email